“This agreement now makes us exclusive licensee of the Alphagenics HPV DNA-based test in China, a country in which there is a very high incidence, unfortunately, of cervical cancer.”
Hun-Chi...
LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (‘Grant’)
Inc. (OTC BB: GLIF) announced today that it has signed an MOU
(Memorandum of Understanding) with Union Clinical...
LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (‘Grant’)
Inc. (OTC BB: GLIF) announced today that it has received a cash infusion
of $400,000. The company intends to...
LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (‘Grant’)
Inc. (OTC BB: GLIF) announced today that it has hired Mr. Kim Liao as
director of Asian business development,...
#12: GLIF News Grant Life Sciences and Diagnostic Technologies Ltd. Are Exploring an Expanded Partnership beyond Their Initially Proposed Association to Develop and Commercialize Grant's Cervical Cancer-Diagnostic Platform
LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (‘Grant’)
Inc. (OTC BB: GLIF) announced today that it is exploring an expanded
partnership with Israel-based Diagnostic...
#11: GLIF News Grant Life Sciences Enters into Memorandum of Understanding (MOU) with i+MED Laboratories Co. Ltd. to Distribute i+MED's Point-of-Care Rapid Diagnostic Tests Via Grant's Established Marketing Channels
LOS ANGELES--(BUSINESS WIRE)--
“This is the third partnership we
have announced in recent weeks, bearing strong testimony that we are
aggressively executing Grant’s...
#10: GLIF News Grant Life Sciences ('Grant') extends to Oct. 15, 2006, a Memorandum of Understanding with Diagnostic Technologies Ltd. ('DTL') to develop and commercialize Grant's cervical cancer-diagnostic platform
LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences Inc. (OTC Bulletin Board: GLIF) announced today that
it has extended to Oct. 15, 2006, a Memorandum of Understanding (MOU)
with...
#9: GLIF News Grant Life Sciences enters into Memorandum of Understanding (MOU) with Chinese medical device company to manufacture and distribute Grant's point-of-care, rapid diagnostic tests in China and Hong Kong
LOS ANGELES--(BUSINESS WIRE)--Sept. 13, 2006-- "When finalized, this relationship will fit with Grant's new corporate strategy: to (1) acquire products and technologies via in-licensing...
#8: GLIF News Grant Life Sciences Receives Purchase Order from India for Two Million Point-of-Care (POC), 'Rapid' Malaria Tests to Be Delivered by Year-End
LOS ANGELES--(BUSINESS WIRE)--Sept. 11, 2006-- "This is an important event, because it demonstrates that we are successfully executing our new corporate strategy, part of which is to drive...
for several weeks if not longer volume has been weak as well as it price, I bought in at .08 thinking I got in at a good time which as we all know it plummeted to .014 I have since did my best to...
MURRAY, Utah--(BUSINESS WIRE)--Nov. 8, 2005--Grant Life Sciences (OTC Bulletin Board: GLIF) announced today that it has shipped its first order of Malaria rapid diagnostic tests, to India. This...
MURRAY, Utah--(BUSINESS WIRE)--Oct. 24, 2005-- Products are now being manufactured and prepared for shipment to distribution channels that are already in place Grant Life Sciences (OTC...
